Prognostic Value of Pretreatment Geriatric Nutrition Risk Index in Lung Cancer Patients: A Meta-Analysis

References

• Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89. doi:10.1002/ijc.33588
   Web of Science ®Google Scholar
• Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021;71(6):466–87. doi:10.3322/caac.21695
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Huang Y, Shen A. The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients: a meta-analysis. Medicine (Baltimore). 2020;99(34):e21718. doi:10.1097/MD.0000000000021718
   PubMed Web of Science ®Google Scholar
• Lu Y, Jiang J, Ren C. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: a meta-analysis. PLoS One. 2020;15(4):e0230979. doi:10.1371/journal.pone.0230979
   PubMed Web of Science ®Google Scholar
• Yang T, Hao L, Yang X, Luo C, Wang G, Lin Cai C, Qi S, Li Z. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis. BMJ Open. 2021;11(9):e049123. doi:10.1136/bmjopen-2021-049123
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang D, Xu WY, Wang YW, Che GW. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in non-small cell lung cancer: a meta-analysis. Oncol Res Treat. 2019;42(10):523–31. doi:10.1159/000501726
   PubMed Web of Science ®Google Scholar
• Zhang H, Gao L, Zhang B, Zhang L, Wang C. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:22618. doi:10.1038/srep22618
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Wu Y, Li J, Che G. Prognostic value of pretreatment albumin to globulin ratio in lung cancer: a meta-analysis. Nutr Cancer. 2021;73(1):75–82. doi:10.1080/01635581.2020.1737155
   PubMed Web of Science ®Google Scholar
• Jin J, Hu K, Zhou Y, Li W. Clinical utility of the modified Glasgow prognostic score in lung cancer: a meta-analysis. PLoS One. 2017;12(9):e0184412. doi:10.1371/journal.pone.0184412
   PubMed Web of Science ®Google Scholar
• Zhu L, Chen S, Ma S, Zhang S. Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis. Springerplus. 2016;5(1):439. doi:10.1186/s40064-016-2093-9
   PubMedGoogle Scholar
• Liu M, Wang L. Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio, and prognostic nutritional index for patients with glioma: a meta-analysis. Medicine (Baltimore). 2020;99(27):e20927. doi:10.1097/MD.0000000000020927
   PubMed Web of Science ®Google Scholar
• Nie R-C, Chen G-M, Wang Y, Yuan S-Q, Zhou J, Duan J-L, Liu W-W, Chen S, Cai M-Y, Li Y-F. Association between body mass index and survival outcomes in patients treated with immune checkpoint inhibitors: meta-analyses of individual patient data. J Immunother. 2021;44(9):371–5. doi:10.1097/CJI.0000000000000389
   PubMed Web of Science ®Google Scholar
• Shukla S, Babcock Z, Pizzi L, Brunetti L. Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials. Curr Med Res Opin. 2021;37(5):811–7. doi:10.1080/03007995.2021.1900091
   PubMed Web of Science ®Google Scholar
• Xie H, Tang S, Wei L, Gan J. Geriatric nutritional risk index as a predictor of complications and long-term outcomes in patients with gastrointestinal malignancy: a systematic review and meta-analysis. Cancer Cell Int. 2020;20(1):530. doi:10.1186/s12935-020-01628-7
   PubMed Web of Science ®Google Scholar
• Zhang X, Tan R, Lam WC, Yao L, Wang X, Cheng CW, Liu F, Chan JC, Aixinjueluo Q, Lau CT, et al. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020). Am J Chin Med. 2020;48(6):1279–313. doi:10.1142/s0192415x20500639
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Chang S, Dong Y, Che G. Risk and influencing factors for subsequent primary lung cancer after treatment of breast cancer: a systematic review and two meta-analyses based on four million cases. J Thorac Oncol. 2021;16(11):1893–1908. doi:10.1016/j.jtho.2021.07.001
   PubMed Web of Science ®Google Scholar
• Shoji F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Takamori S, Katsura M, Toyokawa G, Okamoto T, Maehara Y. Preoperative Geriatric Nutritional Risk Index: a predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer. Surgical Oncology-Oxford. 2017;26(4):483–8. doi:10.1016/j.suronc.2017.09.006
   PubMed Web of Science ®Google Scholar
• Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, et al. Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study. Interact Cardiovasc Thorac Surg. 2018;26(3):389–94. doi:10.1093/icvts/ivx337
   PubMed Web of Science ®Google Scholar
• Lee G, Go S, Kim D, Kim H, Kim J, An HJ, Jang JS, Kim B, Hahn S, Heo DS. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: results from a randomized controlled trial. Thorac Cancer. 2020;11(1):62–71. doi:10.1111/1759-7714.13229
   PubMed Web of Science ®Google Scholar
• Peng SM, Yu N, Ren JJ, Xu JY, Chen GC, et al. The geriatric nutritional risk index as a prognostic factor in patients with advanced non-small-cell lung cancer. Nutr Cancer. 2021;73(11–12):2832–41. doi:10.1080/01635581.2020.1865423
   PubMed Web of Science ®Google Scholar
• Tang M, Li L, Zhang P, Wu X, Wang H. The geriatric nutritional risk index predicts overall survival in geriatric patients with metastatic lung adenocarcinoma. Nutr Cancer. 2020;2020:1–9. doi:10.1080/01635581.2020.1743865
   Web of Science ®Google Scholar
• Asakawa A, Ishibashi H, Matsuyama Y, Fujiwara T, Kobayashi M, et al. Preoperative nutritional status is associated with the prognosis for lung cancer. Asian Cardiovasc Thorac Ann. 2021;29(8):763–71. doi:10.1177/02184923211014002
   PubMedGoogle Scholar
• Sonehara K, Tateishi K, Araki T, Komatsu M, Yamamoto H, Hanaoka M. Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy. Thoracic Cancer. 2021;12(9):1366–72. doi:10.1111/1759-7714.13909
   PubMed Web of Science ®Google Scholar
• Takahashi M, Sowa T, Tokumasu H, Gomyoda T, Okada H, Ota S, Terada Y. Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021;162(4):1257–68.e3. doi:10.1016/j.jtcvs.2020.06.030
   PubMed Web of Science ®Google Scholar
• Li D, Yuan X, Liu J, Li C, Li W. Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J Thorac Dis. 2018;10(9):5298–307. doi:10.21037/jtd.2018.08.51
   PubMed Web of Science ®Google Scholar
• Peng J, Hao Y, Rao B, Cao Y. Prognostic impact of the pre-treatment controlling nutritional status score in patients with non-small cell lung cancer: a meta-analysis. Medicine (Baltimore). 2021;100(26):e26488. doi:10.1097/MD.0000000000026488
   PubMed Web of Science ®Google Scholar
• Lv GY, An L, Sun DW. Geriatric nutritional risk index predicts adverse outcomes in human malignancy: a meta-analysis. Dis Markers. 2019;2019:4796598. doi:10.1155/2019/4796598
   PubMed Web of Science ®Google Scholar